Differential effect of previous antiplatelet use on stroke severity according to stroke mechanism

Stroke

Volumn 41, Issue 6, 2010, Pages 1200-1204

  Kim, Wook Joo ^a   Ko, Youngchai ^b   Yang, Mi Hwa ^a   Im, Sun Hye ^a   Park, Jung Hyun ^c   Lee, Jisung ^d   Lee, Juneyoung ^d   Han, Moon Ku ^a   Bae, Hee Joon ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Dongguk University Gyeongju Hospital   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

Antiplatelet drugs; Cerebral infarction; Stroke classification

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE; TRIFLUSAL;

AGED; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFECT; DRUG USE; EMBOLISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REGISTRIES; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS;

EID: 77953233046     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.580225     Document Type: Article

References (34)

1. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, Gutnikov SA, Edwards P, Mant D, Sackley CM, Farmer A, Sandercock PA, Dennis MS, Warlow CP, Bamford JM, Anslow P. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford vascular study). Lancet. 2004;363:1925-1933.
2. Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH. Aspirin use among U.S. Adults: Behavioral risk factor surveillance system. Am J Prev Med. 2006;30:74-77.
3. The international stroke trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International stroke trial collaborative group. Lancet. 1997;349:1569-1581.
4. Cast: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Cast (Chinese acute stroke trial) collaborative group. Lancet. 1997;349:1641-1649.
5. Grotta JC, Lemak NA, Gary H, Fields WS, Vital D. Does platelet antiaggregant therapy lessen the severity of stroke? Neurology. 1985;35:632-636.
6. Kalra L, Perez I, Smithard DG, Sulch D. Does previous use of aspirin affect outcome in ischemic stroke? Am J Med. 2000;108:205-209.
7. Wilterdink JL, Bendixen B, Adams HP Jr, Woolson RF, Clarke WR, Hansen MD. Effect of previous aspirin use on stroke severity in the Trial of Org 10172 in acute stroke treatment (TOAST). Stroke. 2001;32:2836-2840.
8. Lampl Y, Boaz M, Sadeh M. The significance of prestroke aspirin dosage in fatal outcome of acute stroke. Clin Neuropharmacol. 2005;28:55-59.
9. Sanossian N, Saver JL, Rajajee V, Selco SL, Kim D, Razinia T, Ovbiagele B. Premorbid antiplatelet use and ischemic stroke outcomes. Neurology. 2006;66:319-323.
10. Ovbiagele B, Buck BH, Liebeskind DS, Starkman S, Bang OY, Ali LK, Villablanca JP, Salamon N, Yun SW, Pineda S, Saver JL. Previous antiplatelet use and infarct volume in ischemic stroke. J Neurol Sci. 2008;264:140-144.
11. O'Donnell M, Oczkowski W, Fang J, Kearon C, Silva J, Bradley C, Guyatt G, Gould L, D'Uva C, Kapral M, Silver F. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: An observational study. Lancet Neurol. 2006;5:749-754.
12. De Keyser J, Herroelen L, De Klippel N. Early outcome in acute ischemic stroke is not influenced by the prophylactic use of low-dose aspirin. J Neurol Sci. 1997;145:93-96.
13. Karepov V, Bornstein NM, Hass Y, Korczyn AD. Does daily aspirin diminish severity of first-ever stroke? Arch Neurol. 1997;54:1369-1371.
14. Paciaroni M, Agnelli G, Caso V, Venti M, Alberti A, Milia P, Silvestrelli G, Biagini S. Previous use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke. J Thromb Haemost. 2006;4:1957-1961.
15. Ricci S, Lewis S, Sandercock P. Previous use of aspirin and baseline stroke severity: An analysis of 17,850 patients in the international stroke trial. Stroke. 2006;37:1737-1740.
16. Libman R, Sharfstein S, Barr W. Stroke outcome in patients already taking aspirin. J Stroke Cerebrovasc Dis. 1999;8:423-425.
17. Joseph R, Han E, Tsering C, Grunfeld S, Welch KM. Platelet activity and stroke severity. J Neurol Sci. 1992;108:1-6.
18. Joseph R, D'Andrea G, Oster SB, Welch KM. Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents. Stroke. 1989;20:38-44.
19. Rosenblum WI, El-Sabban F. Platelet aggregation in the cerebral micro-circulation: Effect of aspirin and other agents. Circ Res. 1977;40:320-328.
20. Hallenbeck JM, Furlow TW Jr. Prostaglandin i2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog. Stroke. 1979;10:629-637.
21. Kuhn W, Muller T, Bttner T, Gerlach M. Aspirin as a free radical scavenger: Consequences for therapy of cerebrovascular ischemia. Stroke. 1995;26:1959-1960.
22. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappab activation. Science. 1996;274:1383-1385.
23. Riepe MW, Kasischke K, Raupach A. Acetylsalicylic acid increases tolerance against hypoxic and chemical hypoxia. Stroke. 1997;28:2006-2011.
24. Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC. Ischemic stroke in patients with atrial fibrillation: Effect of aspirin according to stroke mechanism. Stroke prevention in atrial fibrillation investigators. Neurology. 1993;43:32-36.
25. Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E. Cardioembolic vs. Noncardioembolic strokes in atrial fibrillation: Frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis. 2000;10:39-43.
26. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35-41.
27. Lee BC, Roh JK. International experience in stroke registries: Korean stroke registry. Am J Prev Med. 2006;31:S243-S245.
28. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: The cardiovascular health study. Arch Neurol. 1998;55:1217-1225.
29. Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989;46:660-662.
30. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Inter-observer agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
31. Poppert H, Sadikovic S, Sander K, Wolf O, Sander D. Embolic signals in unselected stroke patients: Prevalence and diagnostic benefit. Stroke. 2006;37:2039-2043.
32. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711.
33. Kim C, Beckles GL. Cardiovascular disease risk reduction in the behavioral risk factor surveillance system. Am J Prev Med. 2004;27:1-7.
34. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 2003;41:56-61.